FI901883A0 - Förfarande för framställning av terapeutiskt verksamma 2-substituerade N,N'-ditrimetoxibensoylpiperaziner - Google Patents

Förfarande för framställning av terapeutiskt verksamma 2-substituerade N,N'-ditrimetoxibensoylpiperaziner

Info

Publication number
FI901883A0
FI901883A0 FI901883A FI901883A FI901883A0 FI 901883 A0 FI901883 A0 FI 901883A0 FI 901883 A FI901883 A FI 901883A FI 901883 A FI901883 A FI 901883A FI 901883 A0 FI901883 A0 FI 901883A0
Authority
FI
Finland
Prior art keywords
ditrimethoxybenzoylpiperazines
substituted
preparation
therapeutically active
therapeutically
Prior art date
Application number
FI901883A
Other languages
English (en)
Finnish (fi)
Other versions
FI92058C (sv
FI92058B (sv
Inventor
Pierre Braquet
Eduardo Pirotzky
Jean-Jacques Godfroid
Francoise Heymans
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of FI901883A0 publication Critical patent/FI901883A0/sv
Application granted granted Critical
Publication of FI92058B publication Critical patent/FI92058B/sv
Publication of FI92058C publication Critical patent/FI92058C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI901883A 1989-04-15 1990-04-12 Förfarande för framställning av terapeutiskt verksamma 2-substituerade N,N'-ditrimetoxibensoylpiperaziner FI92058C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898908587A GB8908587D0 (en) 1989-04-15 1989-04-15 New 2-substituted n,n'-ditrimethoxybenzoyl piperazines
GB8908587 1989-04-15

Publications (3)

Publication Number Publication Date
FI901883A0 true FI901883A0 (sv) 1990-04-12
FI92058B FI92058B (sv) 1994-06-15
FI92058C FI92058C (sv) 1994-09-26

Family

ID=10655129

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901883A FI92058C (sv) 1989-04-15 1990-04-12 Förfarande för framställning av terapeutiskt verksamma 2-substituerade N,N'-ditrimetoxibensoylpiperaziner

Country Status (32)

Country Link
US (1) US5019576A (sv)
JP (1) JP2633709B2 (sv)
KR (1) KR900016178A (sv)
AR (1) AR247736A1 (sv)
AT (1) AT399337B (sv)
AU (1) AU631334B2 (sv)
BE (1) BE1007245A3 (sv)
CA (1) CA2014521C (sv)
CH (1) CH681301A5 (sv)
DE (1) DE4011925A1 (sv)
DK (1) DK91890A (sv)
DZ (1) DZ1407A1 (sv)
ES (1) ES2019554A6 (sv)
FI (1) FI92058C (sv)
FR (2) FR2645743B1 (sv)
GB (2) GB8908587D0 (sv)
GR (1) GR1000355B (sv)
HK (1) HK95092A (sv)
IE (1) IE65058B1 (sv)
IN (1) IN175799B (sv)
IT (1) IT1241631B (sv)
LU (1) LU87719A1 (sv)
MA (1) MA21805A1 (sv)
NL (1) NL9000798A (sv)
NO (1) NO176098C (sv)
NZ (1) NZ233250A (sv)
OA (1) OA09446A (sv)
PT (1) PT93736B (sv)
SE (1) SE505186C2 (sv)
SG (1) SG92092G (sv)
TN (1) TNSN90051A1 (sv)
ZA (1) ZA902566B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344830A (en) * 1992-12-10 1994-09-06 Merck & Co., Inc. N,N-diacylpiperazine tachykinin antagonists
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
US5883098A (en) * 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
US5610165A (en) * 1994-02-17 1997-03-11 Merck & Co., Inc. N-acylpiperidine tachykinin antagonists
US5795894A (en) * 1995-05-02 1998-08-18 Schering Corporation Piperazino derivatives as neurokinn antagonists
JP4173912B2 (ja) * 1995-05-02 2008-10-29 シェーリング コーポレイション ニューロキニンアンタゴニストとしてのピペラジノ誘導体
BR9610277A (pt) * 1995-08-31 1999-07-06 Schering Corp Derivados de piperazino como antagonistas de neurowuinina
US5892039A (en) * 1995-08-31 1999-04-06 Schering Corporation Piperazino derivatives as neurokinin antagonists
US5869488A (en) * 1996-05-01 1999-02-09 Schering Corporation Piperazino derivatives as neurokinin antagonists
FR2780649B1 (fr) * 1998-07-06 2001-03-09 Univ Paris Vii Denis Diderot Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1243991A (en) * 1968-06-10 1971-08-25 Ici Ltd Piperidine, morpholine and piperazine derivatives
FR2209560A1 (en) * 1972-12-07 1974-07-05 Degussa N-(Trialkoxyaroyl)-ethylenediamine derivs - useful as cardioactive medicaments, exhibit anti-ischaemic activity comparable to nitroglycerin
IL85700A0 (en) * 1987-03-24 1988-08-31 Takeda Chemical Industries Ltd 1,4-disubstituted piperazine compounds,their production and use
EP0318235A3 (en) * 1987-11-25 1991-05-02 Takeda Chemical Industries, Ltd. Paf antagonist, 1,4-disubstituted piperazine compounds and production thereof
PT90619B (pt) * 1988-05-23 1994-10-31 Glaxo Group Ltd Processo para a preparacao de compostos de piperazina
GB8823775D0 (en) * 1988-10-11 1988-11-16 Scras New 2-carbonyl substituted n n'-di-(trimethoxybenzoyl)piperazines
GB8823776D0 (en) * 1988-10-11 1988-11-16 Scras New 2-methoxycarbonyl sustituted n n'-di-(trimethoxybenzoyl)piperazines
US4997836A (en) * 1988-11-11 1991-03-05 Takeda Chemical Industries, Ltd. Trisubstituted piperazine compounds, their production and use

Also Published As

Publication number Publication date
AU5326190A (en) 1990-11-01
FR2645743A1 (fr) 1990-10-19
PT93736A (pt) 1990-11-20
AU631334B2 (en) 1992-11-19
HK95092A (en) 1992-12-04
AT399337B (de) 1995-04-25
SG92092G (en) 1992-12-04
LU87719A1 (fr) 1990-07-24
JPH02292266A (ja) 1990-12-03
SE505186C2 (sv) 1997-07-14
TNSN90051A1 (fr) 1991-03-05
FR2645859A1 (fr) 1990-10-19
GR1000355B (el) 1992-06-25
IE901314L (en) 1990-10-15
GB8908587D0 (en) 1989-06-01
FR2645859B1 (fr) 1992-06-05
FR2645743B1 (fr) 1992-06-05
NO901631D0 (no) 1990-04-10
GB2230262B (en) 1992-02-26
NO176098C (no) 1995-02-01
IT9020020A0 (it) 1990-04-12
GB9007612D0 (en) 1990-05-30
NZ233250A (en) 1991-03-26
GR900100270A (en) 1991-09-27
FI92058C (sv) 1994-09-26
BE1007245A3 (fr) 1995-05-02
DE4011925A1 (de) 1990-10-18
IT9020020A1 (it) 1991-10-12
SE9001269D0 (sv) 1990-04-06
KR900016178A (ko) 1990-11-12
GB2230262A (en) 1990-10-17
NL9000798A (nl) 1990-11-01
FI92058B (sv) 1994-06-15
AR247736A1 (es) 1995-03-31
DZ1407A1 (fr) 2004-09-13
JP2633709B2 (ja) 1997-07-23
IE65058B1 (en) 1995-10-04
SE9001269L (sv) 1990-10-16
DK91890D0 (da) 1990-04-11
MA21805A1 (fr) 1990-12-31
NO901631L (no) 1990-10-16
ES2019554A6 (es) 1991-06-16
ZA902566B (en) 1991-01-30
IN175799B (sv) 1995-08-26
CA2014521C (en) 1997-09-09
NO176098B (no) 1994-10-24
IT1241631B (it) 1994-01-25
CH681301A5 (sv) 1993-02-26
DK91890A (da) 1990-10-16
CA2014521A1 (en) 1990-10-15
US5019576A (en) 1991-05-28
ATA86690A (de) 1994-09-15
PT93736B (pt) 1996-09-30
OA09446A (fr) 1992-10-15

Similar Documents

Publication Publication Date Title
FI890282A (sv) Förfarande för framställning av terapeutiskt användbara 23,24-didehydro-25-hydroxikalciferolderivat
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
NO900032D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser.
FI880467A (sv) Förfarande för framställning av terapeutiskt användbara substituerade 3,4-dihydro-2H-benzopyraner
FI871087A (sv) Förfarande för framställning av terapeutiskt användbara 1,2,3,4-tetrahydro-3-karbamoyl-2-tioxo/oxo-5-pyrimidinkarboxylsyraderivat
FI873350A (sv) Förfarande för framställning av terapeutiskt användbara 1,4-dihydropyridinderivat
NO177096C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte isokinoliner
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
FI884660A (sv) Förfarande för framställning av terapeutiskt aktiva 2,2-dimetylkromenderivat
FI892684A0 (sv) Förfarande för framställning av terapeutiskt aktiva 4-oxo-imidazo/1,5-a/kinoxalinderivat
FI901883A0 (sv) Förfarande för framställning av terapeutiskt verksamma 2-substituerade N,N'-ditrimetoxibensoylpiperaziner
FI903077A0 (sv) Förfarande för framställning av terapeutiskt aktiva R(-)-3-kinuklidinolderivat
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
FI100799B (sv) Förfarande för framställning av terapeutiskt aktiva tetralinderivat
FI880190A0 (sv) Förfarande för framställning av terapeutiskt verksamma tetrahydrofuranderivat
FI900145A0 (sv) Förfarande för framställning av farmaceutiskt användbara 1,1-dioxo-cefem-4-karbotiolsyraderivat
NO881768L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
FI89047C (sv) Förfarande för framställning av terapeutiskt användbara 5-aryl-2,4-dia lkyl-3H-1,2,4-triazol-3-tioner
FI93216C (sv) Analogiförfarande för framställning av terapeutiskt användbara 1,3-dioxanalkensyraderivat
FI893121A (sv) Förfarande för framställning av terapeutiskt aktiva 6,21-dimetyl-19-norprogestronderivat
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
NO175746C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktivt 1-etyl-fenoksatiin-10,10-dioksyd

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: SOCIETE DE CONSEILS DE RECHERCHES ET D APPLICATION